Thus, we propose that elevating endogenous 2-AG by inactivating MAGL has beneficial effects on suppressing COX-2-derived PGE2 signaling and thereby contributes to treating, ameliorating, or preventing AD-like progression in NO2-polluted areas. The gene discussed is MGLL; the disease is Alzheimer disease.